The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average ...

Proposed cuts to Medicaid will have significant impacts on the health industry. One area that will be heavily impacted by ...

On Sunday, President Trump posted to Truth Social that he planned on implementing a most-favored-nation policy for ...

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement challenges, shifting distribution models, and expanding the drugs’ potential into ...

The Hardest Job in Biopharma? The Vice President of Market Access ...

The Hardest Job in Biopharma? The Vice President of Market Access ...

The Hardest Job in Biopharma? The Vice President of Market Access ...

The Hardest Job in Biopharma? The Vice President of Market Access ...

The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...